4 ML bumetanide 0.25 MG/ML Injection — RxCUI 1727569
RxNorm drug concept · Semantic clinical drug
RxCUI 1727569
Semantic clinical drug · SCD
● Current RxNorm concept 27 FDA products
29 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1727569
Official name4 ML bumetanide 0.25 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbumetanide 1 MG per 4 ML Injection; bumetanide 1 MG in 4 ML Injection
FDA products mapped27
Package NDCs mapped29
Reported Medicaid activity (SDUD)455 prescriptions · 10 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Bumetanide: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Think of it as a very efficient 'water pill.' Your kidneys normally recycle most of the salt that flows through them, and water follows that salt back into your bloodstream. Bumeta...
- What is bumetanide actually doing in my body?
- Bumetanide works fast. If you take a tablet, you'll usually feel the urge to urinate within 30 to 60 minutes, with the strongest effect around 1 to 2 hours. Most of the diuretic ac...
- When will I notice it working, and how long does it last?
🕸️ Concept Web — How 4 ML bumetanide 0.25 MG/ML Injection Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
4 ML bumetanide 0.25 MG/ML Injection
RxCUI 1727569 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Bumetanide
1808IN
-
Bumetanide
-
Dose forms 4
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Bumetanide Injection
1727568SCDF -
Bumetanide Injectable Product
1151347SCDG -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Bumetanide Injection
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Bumetanide 0.25 MG/ML
315499SCDC
-
Bumetanide 0.25 MG/ML
Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Bumetanide 0.25 MG/ML
SCDC · 315499 -
Bumetanide Injection
SCDF · 1727568 -
Bumetanide Injectable Product
SCDG · 1151347
📦 FDA Products & Package NDCs
27 products · 29 package NDCs
29 package NDCs map to RxCUI 1727569 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00641-6007-10 | 10 VIAL in 1 CARTON (0641-6007-10) / 10 mL in 1 VIAL (0641-... | Bumetanide | Hikma Pharmaceuticals USA Inc. | 2008-04-30 |
| 00641-6008-10 | 10 VIAL in 1 CARTON (0641-6008-10) / 4 mL in 1 VIAL (0641-6... | Bumetanide | Hikma Pharmaceuticals USA Inc. | 2008-04-30 |
| 00641-6284-10 | 10 VIAL in 1 CARTON (0641-6284-10) / 4 mL in 1 VIAL (0641-6... | Bumetanide | Hikma Pharmaceuticals USA Inc. | 2008-04-30 |
| 00641-6285-10 | 10 VIAL in 1 CARTON (0641-6285-10) / 10 mL in 1 VIAL (0641-... | Bumetanide | Hikma Pharmaceuticals USA Inc. | 2008-04-30 |
| 25021-0321-04 | 10 VIAL in 1 CARTON (25021-321-04) / 4 mL in 1 VIAL | Bumetanide | Sagent Pharmaceuticals | 2024-06-01 |
| 25021-0321-10 | 10 VIAL in 1 CARTON (25021-321-10) / 10 mL in 1 VIAL | Bumetanide | Sagent Pharmaceuticals | 2024-06-01 |
| 31722-0368-32 | 10 VIAL, SINGLE-DOSE in 1 CARTON (31722-368-32) / 4 mL in 1... | Bumetanide | Camber Pharmaceuticals, Inc. | 2025-02-27 |
| 31722-0369-32 | 10 VIAL, MULTI-DOSE in 1 CARTON (31722-369-32) / 10 mL in 1... | Bumetanide | Camber Pharmaceuticals, Inc. | 2025-02-27 |
| 51662-1449-01 | 4 mL in 1 VIAL (51662-1449-1) | BUMETANIDE | HF Acquisition Co LLC, DBA HealthFirst | 2020-01-11 |
| 55154-1527-05 | 5 VIAL in 1 BAG (55154-1527-5) / 4 mL in 1 VIAL | Bumetanide | Cardinal Health 107, LLC | 2024-10-21 |
| 65219-0570-04 | 10 VIAL, SINGLE-DOSE in 1 CARTON (65219-570-04) / 4 mL in 1... | Bumetanide | Fresenius Kabi USA, LLC | 2022-09-26 |
| 65219-0572-10 | 10 VIAL, MULTI-DOSE in 1 CARTON (65219-572-10) / 10 mL in 1... | Bumetanide | Fresenius Kabi USA, LLC | 2022-09-26 |
| 67184-0593-02 | 10 VIAL in 1 CARTON (67184-0593-2) / 4 mL in 1 VIAL (67184-... | Bumetanide | Qilu Pharmaceutical Co., Ltd. | 2024-09-19 |
| 67184-0594-02 | 10 VIAL in 1 CARTON (67184-0594-2) / 10 mL in 1 VIAL (67184... | Bumetanide | Qilu Pharmaceutical Co., Ltd. | 2024-09-19 |
| 68083-0496-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (68083-496-10) / 4 mL in 1... | Bumetanide | Gland Pharma Limited | 2022-05-26 |
| 68083-0497-10 | 10 VIAL, MULTI-DOSE in 1 CARTON (68083-497-10) / 10 mL in 1... | Bumetanide | Gland Pharma Limited | 2022-05-26 |
| 68462-0469-54 | 10 VIAL, SINGLE-DOSE in 1 CARTON (68462-469-54) / 4 mL in 1... | Bumetanide | GLENMARK PHARMACEUTICALS INC., USA | 2023-01-01 |
| 68462-0470-54 | 10 VIAL, MULTI-DOSE in 1 CARTON (68462-470-54) / 10 mL in 1... | Bumetanide | GLENMARK PHARMACEUTICALS INC., USA | 2023-01-01 |
| 70748-0323-10 | 10 VIAL in 1 CARTON (70748-323-10) / 4 mL in 1 VIAL | BUMETANIDE | Lupin Pharmaceuticals, Inc. | 2024-11-11 |
| 70748-0323-11 | 10 VIAL in 1 CARTON (70748-323-11) / 10 mL in 1 VIAL | BUMETANIDE | Lupin Pharmaceuticals, Inc. | 2024-11-11 |
| 72162-2633-02 | 10 VIAL in 1 CARTON (72162-2633-2) / 4 mL in 1 VIAL (72162-... | Bumetanide | Bryant Ranch Prepack | 2026-05-06 |
| 72205-0101-07 | 10 VIAL in 1 CARTON (72205-101-07) / 4 mL in 1 VIAL (72205-... | Bumetanide | Novadoz Pharmaceuticals LLC | 2022-08-06 |
| 72205-0102-07 | 10 VIAL in 1 CARTON (72205-102-07) / 10 mL in 1 VIAL (72205... | Bumetanide | Novadoz Pharmaceuticals LLC | 2022-08-06 |
| 72572-0040-10 | 10 VIAL in 1 CARTON (72572-040-10) / 4 mL in 1 VIAL (72572-... | Bumetanide | Civica, Inc. | 2022-03-07 |
| 72572-0041-10 | 10 VIAL in 1 CARTON (72572-041-10) / 10 mL in 1 VIAL (72572... | Bumetanide | Civica, Inc. | 2022-03-07 |
| 83301-0080-02 | 10 VIAL, SINGLE-DOSE in 1 CARTON (83301-0080-2) / 4 mL in 1... | Bumetanide | Mullan Pharmaceutical Inc. | 2025-08-12 |
| 83301-0081-02 | 10 VIAL, MULTI-DOSE in 1 CARTON (83301-0081-2) / 10 mL in 1... | Bumetanide | Mullan Pharmaceutical Inc. | 2026-01-09 |
| 83854-0007-10 | 10 VIAL in 1 CARTON (83854-007-10) / 4 mL in 1 VIAL (83854-... | Bumetanide | Anthea Pharma Private Limited | 2026-02-27 |
| 83854-0035-10 | 10 VIAL in 1 CARTON (83854-035-10) / 10 mL in 1 VIAL (83854... | Bumetanide | Anthea Pharma Private Limited | 2026-06-30 |
Observed labelers:
Hikma Pharmaceuticals USA Inc. (4) ·
Anthea Pharma Private Limited (2) ·
Camber Pharmaceuticals, Inc. (2) ·
Civica, Inc. (2) ·
Fresenius Kabi USA, LLC (2) ·
Gland Pharma Limited (2)
· +9 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J1939 | Inj, bumetanide, 0.5 mg | 18 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.